These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 1908171)

  • 1. Heterotopic ossification following total hip arthroplasty: a review.
    Hu HP; Slooff TJ; van Horn JR
    Acta Orthop Belg; 1991; 57(2):169-82. PubMed ID: 1908171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterotopic bone formation after total hip arthroplasty.
    Thomas BJ
    Orthop Clin North Am; 1992 Apr; 23(2):347-58. PubMed ID: 1570146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
    Macfarlane RJ; Ng BH; Gamie Z; El Masry MA; Velonis S; Schizas C; Tsiridis E
    Expert Opin Pharmacother; 2008 Apr; 9(5):767-86. PubMed ID: 18345954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy to prevent heterotopic ossification in cementless total hip arthroplasty.
    Linclau L; Dokter G; Debois JM; Gutwirth P
    Acta Orthop Belg; 1994; 60(2):220-4. PubMed ID: 8053324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [External radiotherapy or non-steroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement].
    Zouhair A; Ozsahin M; Mouhsine E; Leyvraz PF; Mirimanoff RO; Coucke PA
    Schweiz Med Wochenschr; 1999 Mar; 129(9):370-6. PubMed ID: 10198948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification after total hip arthroplasty.
    Nilsson OS
    Semin Arthroplasty; 1992 Jul; 3(3):172-7. PubMed ID: 10147776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification.
    Kjaersgaard-Andersen P; Schmidt SA
    Clin Orthop Relat Res; 1991 Feb; (263):78-86. PubMed ID: 1899640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterotopic ossification in patients after total hip replacement.
    Stołtny T; Koczy B; Wawrzynek W; Miszczyk L
    Ortop Traumatol Rehabil; 2007; 9(3):264-72. PubMed ID: 17721424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis.
    Balboni TA; Gobezie R; Mamon HJ
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1289-99. PubMed ID: 16863921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty.
    Gebuhr P; Wilbek H; Soelberg M
    Clin Orthop Relat Res; 1995 May; (314):166-9. PubMed ID: 7634631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single dose 6 Gy prophylaxis for heterotopic ossification after total hip arthroplasty.
    Fingeroth RJ; Ahmed AQ
    Clin Orthop Relat Res; 1995 Aug; (317):131-40. PubMed ID: 7671467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiotherapy as prevention of heterotopic ossification--preliminary results].
    Miszczyk L; Spindel J; Maciejewski B; Walichiewicz P; Tarnawski R; Horzela A; Woźniak G
    Przegl Lek; 2004; 61(2):61-4. PubMed ID: 15230142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
    van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
    Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterotopic bone formation in total hip arthroplasty: predisposing factors, classification and the significance for clinical outcome.
    Schara K; Herman S
    Acta Chir Orthop Traumatol Cech; 2001; 68(2):105-8. PubMed ID: 11706718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of radiotherapy in the prevention of heterotopic ossification in patients with total hip replacement].
    Marziano C; Pichi E; Chiarlone R; Luzi G; Siccardi C
    Radiol Med; 1996 Dec; 92(6):766-9. PubMed ID: 9122469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postoperative radiotherapy in the prevention of heterotopic ossification after endoprosthetic hip joint replacement].
    Heyd R; Strassmann G; Kirchner J; Schopohl B; Böttcher HD
    Strahlenther Onkol; 1996 Oct; 172(10):543-52. PubMed ID: 8966671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement results of a prospective study in 462 hips.
    Koelbl O; Seufert J; Pohl F; Tauscher A; Lehmann H; Springorum HW; Flentje M
    Strahlenther Onkol; 2003 Nov; 179(11):767-73. PubMed ID: 14605747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Para-articular (ectopic or heterotopic) ossification following total hip prosthesis].
    Rudicel S
    Orthopade; 1985 Feb; 14(1):54-7. PubMed ID: 3921900
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical effect of etidronate disodium (EHDP) on heterotopic ossification following total hip arthroplasty.
    Yutani Y; Ohashi H; Nishimura N; Yamano Y
    Osaka City Med J; 1995 Dec; 41(2):63-73. PubMed ID: 8778647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterotopic ossification after total hip arthroplasty.
    Cohn RM; Schwarzkopf R; Jaffe F
    Am J Orthop (Belle Mead NJ); 2011 Nov; 40(11):E232-5. PubMed ID: 22263220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.